Trustbridge Partners
VC Fund
Boston, United States
Trustbridge Partners is a VC fund in Boston focused on Education and Health Care. Trustbridge is a growth-oriented private equity firm with offices in Boston, Shanghai, and Hong Kong. The firm invests globally in innovative, high quality growth opportunities in various stages across Technology, Healthcare and Media. Founded and managed by entrepreneurs and operators, Trustbridge provides patient, long-term capital and partnerswith management teams building products and services that improve lives globally. Utilizing a growing, global portfolio and deep operational expertise, the firm has a particular focus on helping its portfolio companies enter new international markets, including China.
- Total investments:
- 115
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $1.6B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Trustbridge Partners invests in
Stages Trustbridge Partners invests in
Countries Trustbridge Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Series A
- $1.5M–$30M
- Series B
- $13M–$57M
- Series C
- $23M–$100M
Investment Focus
Industry
- Education 14 (12%)
- Health Care 14 (12%)
- EdTech 12 (10%)
- Medical 12 (10%)
- Software 12 (10%)
Stage
- Series A 33 (29%)
- Series C 22 (19%)
- Series B 21 (18%)
- Angel 8 (7%)
- Series D 6 (5%)
Country
- China 67 (58%)
- United States 14 (12%)
- United Kingdom 2 (2%)
- India 1 (1%)
- Norway 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Sullivan
Vice Chairman
|
Vice Chairman | Total investments: 2 | Find email | |
|
Shujun Li
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 0 | Find email | |
Steve Kent
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
Aimun Malik
Investor
|
Investor | Total investments: 0 | Find email | |
Feng Ge
Managing Partner
|
Managing Partner | Total investments: 2 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Beijing Ronglian Yitong Information Technology Co., Ltd, established in 2009, is the first and also the largest open platform that provides full communication capability. Cloud communications by the professional communication capabilities packaged into API interface for web, desktop and mobile applications can easily embed calls, conferencing,call center, SMS /intelligent call, mobile IM functions. | Venture - Series Unknown / May 13, 2026 | ||
| Metafoodx is on a mission to solve the challenge of food waste because we believe that it is one of the most critical factors for achieving global sustainability. We have assembled a team that shares a passion for helping foodservice businesses and has great insight into how the challenges of food production can be solved with artificialintelligence.Metafoodx helps foodservice businesses prevent food waste and optimize production planning through an AI-powered software service. We remove the data gap between back-kitchen production and true consumption through industry-first real-time consumption tracking. We deliver customers value by providing planning tools with actionable insights and by generating automatic alerts and reminders to help staff streamline actions. Metafoodx delivers business impact by reducing food waste, lowering COGS, and increasing operational efficiency. Our product consists of a data analytics cloud and a set of consumption tracking devices. The tracking devices deploy seamlessly to service environments and collect granular consumption data. The cloud service discovers consumption trends, generates production guidance, and delivers timely alerts and insightful reports. | $9.4M / Series A / May 15, 2025 | ||
| Future offers one-on-one digital training with fitness coaches, at home, at the gym, or on-the-go. Future pairs its clients with coaches who have trained pro athletes, Hollywood celebrities, and working professionals. | Series C / Sep 19, 2024 | ||
| Cherre gives clients direct control over moving and managing their data, while providing the visibility, observability, and validation tools needed to improve data quality, support governance strategies, and establish data lineage for the rapidly changing regulatory environment. With Cherre, clients can automate workflows, optimize processes,maximize efficiencies, reduce risks, and identify opportunities to increase profitability by making smarter decisions with confidence. Cherre partners with the largest data providers, applications, and solution and service providers in the industry, creating a full ecosystem that supports clients across all their data needs. | $30M / Series C / Sep 18, 2024 | ||
| Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases. | $28.1M / Series B / Feb 07, 2024 | ||
| Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions. | $25.8M / Series B / Jan 11, 2023 | ||
| G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc). | $200M / Private Equity / Feb 15, 2022 | ||
| Future offers one-on-one digital training with fitness coaches, at home, at the gym, or on-the-go. Future pairs its clients with coaches who have trained pro athletes, Hollywood celebrities, and working professionals. | $75M / Series C / Feb 03, 2022 | ||
| Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients toget better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors. | $125M / Post-IPO Equity / Dec 06, 2021 | ||
|
Fengxingzhitu
|
Fengxingzhitu engages in R&D of AI system. | Series B / Nov 17, 2021 | |
| See all 115 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Trustbridge Partners invest in?
Trustbridge Partners invests primarily in Education, Health Care and EdTech startups, most often at Series A and Series C stage. Most of the 115 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Trustbridge Partners's check size?
Trustbridge Partners typically joins rounds of $1.5M–$30M at Series A, $13M–$57M at Series B and $23M–$100M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Trustbridge Partners participates in.
How do I contact Trustbridge Partners?
Public channels for Trustbridge Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Trustbridge Partners?
The team at Trustbridge Partners includes Daniel Sullivan (Vice Chairman), Shujun Li (Founder & Managing Partner) and Steve Kent (Operating Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
